Rushita A. Bagchi

1.7k total citations
47 papers, 1.3k citations indexed

About

Rushita A. Bagchi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Rushita A. Bagchi has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Cardiology and Cardiovascular Medicine and 13 papers in Physiology. Recurrent topics in Rushita A. Bagchi's work include Cardiac Fibrosis and Remodeling (14 papers), Adipose Tissue and Metabolism (9 papers) and Histone Deacetylase Inhibitors Research (8 papers). Rushita A. Bagchi is often cited by papers focused on Cardiac Fibrosis and Remodeling (14 papers), Adipose Tissue and Metabolism (9 papers) and Histone Deacetylase Inhibitors Research (8 papers). Rushita A. Bagchi collaborates with scholars based in United States, Canada and Australia. Rushita A. Bagchi's co-authors include Michael P. Czubryt, Timothy A. McKinsey, Kate L. Weeks, Patricia Roche, Maria A. Cavasin, Andrew S. Riching, Nina Aroutiounova, Kunhua Song, Jill R. Johnson and Varsha Kanabar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Rushita A. Bagchi

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rushita A. Bagchi United States 23 643 344 193 189 184 47 1.3k
Fumihiro Sanada Japan 22 676 1.1× 331 1.0× 118 0.6× 360 1.9× 123 0.7× 42 1.4k
Firdos Ahmad United Arab Emirates 22 729 1.1× 400 1.2× 159 0.8× 191 1.0× 113 0.6× 104 1.6k
Masayuki Hosoi Japan 19 472 0.7× 366 1.1× 140 0.7× 179 0.9× 222 1.2× 42 1.4k
Ilaria Canobbio Italy 27 614 1.0× 342 1.0× 192 1.0× 151 0.8× 161 0.9× 57 1.9k
Yan Ru Su United States 27 937 1.5× 242 0.7× 187 1.0× 249 1.3× 117 0.6× 65 1.8k
Akiko Ishii Japan 24 738 1.1× 222 0.6× 111 0.6× 125 0.7× 108 0.6× 75 1.6k
Carlos Tarín Spain 17 469 0.7× 213 0.6× 73 0.4× 211 1.1× 190 1.0× 17 1.2k
Hanna Leskinen Finland 27 748 1.2× 999 2.9× 168 0.9× 350 1.9× 174 0.9× 53 1.9k
Rok Humar Switzerland 21 688 1.1× 151 0.4× 143 0.7× 152 0.8× 142 0.8× 42 1.4k
Tatsuhiko Mori Japan 20 257 0.4× 328 1.0× 147 0.8× 140 0.7× 131 0.7× 75 1.1k

Countries citing papers authored by Rushita A. Bagchi

Since Specialization
Citations

This map shows the geographic impact of Rushita A. Bagchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rushita A. Bagchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rushita A. Bagchi more than expected).

Fields of papers citing papers by Rushita A. Bagchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rushita A. Bagchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rushita A. Bagchi. The network helps show where Rushita A. Bagchi may publish in the future.

Co-authorship network of co-authors of Rushita A. Bagchi

This figure shows the co-authorship network connecting the top 25 collaborators of Rushita A. Bagchi. A scholar is included among the top collaborators of Rushita A. Bagchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rushita A. Bagchi. Rushita A. Bagchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagchi, Rushita A., et al.. (2025). Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity. Cells. 14(18). 1471–1471.
2.
Schuetze, Katherine B., Matthew S. Stratton, Rushita A. Bagchi, et al.. (2024). BRD4 inhibition rewires cardiac macrophages toward a protective phenotype marked by low MHC class II expression. American Journal of Physiology-Heart and Circulatory Physiology. 328(2). H294–H309. 2 indexed citations
3.
Robinson, Emma, et al.. (2024). Gravi-D peptide disrupts HDAC11 association with an AKAP to stimulate adipocyte thermogenic signaling. Journal of Clinical Investigation. 134(9).
4.
Robinson, Emma, et al.. (2023). HDAC11 inhibition triggers bimodal thermogenic pathways to circumvent adipocyte catecholamine resistance. Journal of Clinical Investigation. 133(19). 8 indexed citations
5.
Çakır, Işın, Rushita A. Bagchi, Masoud Ghamari‐Langroudi, et al.. (2022). Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity. Nature Metabolism. 4(1). 44–59. 46 indexed citations
6.
Nagalingam, Raghu S., David Cheung, Sayantan Jana, et al.. (2022). Scleraxis and fibrosis in the pressure-overloaded heart. European Heart Journal. 43(45). 4739–4750. 26 indexed citations
7.
Bagchi, Rushita A., et al.. (2021). Enhancing NAD+ Metabolome in Cardiovascular Diseases: Promises and Considerations. Frontiers in Cardiovascular Medicine. 8. 716989–716989. 4 indexed citations
8.
Stratton, Matthew S., Rushita A. Bagchi, Marina Barreto Felisbino, et al.. (2019). Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation. Circulation Research. 125(7). 662–677. 123 indexed citations
9.
Gil, Hyo‐Wook, Rushita A. Bagchi, Sara A. Wennersten, et al.. (2019). Metabolomics assessment reveals oxidative stress and altered energy production in the heart after ischemic acute kidney injury in mice. Kidney International. 95(3). 590–610. 66 indexed citations
10.
Bagchi, Rushita A. & Kate L. Weeks. (2019). Histone deacetylases in cardiovascular and metabolic diseases. Journal of Molecular and Cellular Cardiology. 130. 151–159. 82 indexed citations
11.
Hu, Tianjing, et al.. (2019). HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression. Journal of Biological Chemistry. 294(21). 8640–8652. 40 indexed citations
12.
Nagalingam, Raghu S., et al.. (2018). Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition. American Journal of Physiology-Heart and Circulatory Physiology. 315(3). H658–H668. 28 indexed citations
13.
Bagchi, Rushita A., et al.. (2016). Regulation of fibronectin gene expression in cardiac fibroblasts by scleraxis. Cell and Tissue Research. 366(2). 381–391. 31 indexed citations
14.
Bagchi, Rushita A., et al.. (2016). Regulation of scleraxis transcriptional activity by serine phosphorylation. Journal of Molecular and Cellular Cardiology. 92. 140–148. 13 indexed citations
15.
Bagchi, Rushita A., Patricia Roche, Nina Aroutiounova, et al.. (2016). The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype. BMC Biology. 14(1). 21–21. 56 indexed citations
16.
Roche, Patricia, et al.. (2015). Intracellular Signaling of Cardiac Fibroblasts. Comprehensive physiology. 5(2). 721–760. 35 indexed citations
17.
Bagchi, Rushita A., et al.. (2015). Development of a high throughput luciferase reporter gene system for screening activators and repressors of human collagen Iα2 gene expression. Canadian Journal of Physiology and Pharmacology. 93(10). 887–892. 4 indexed citations
18.
Bagchi, Rushita A. & Michael P. Czubryt. (2012). Synergistic roles of scleraxis and Smads in the regulation of collagen 1α2 gene expression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(10). 1936–1944. 54 indexed citations
19.
Wright, David B., Thomas Trian, Sana Siddiqui, et al.. (2012). Phenotype modulation of airway smooth muscle in asthma. Pulmonary Pharmacology & Therapeutics. 26(1). 42–49. 80 indexed citations
20.
Wright, David B., Thomas Trian, Sana Siddiqui, et al.. (2012). Functional phenotype of airway myocytes from asthmatic airways. Pulmonary Pharmacology & Therapeutics. 26(1). 95–104. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumihiro Sanada Breakdown of academic impact, for papers by Firdos Ahmad Breakdown of academic impact, for papers by Masayuki Hosoi Breakdown of academic impact, for papers by Ilaria Canobbio Breakdown of academic impact, for papers by Yan Ru Su Breakdown of academic impact, for papers by Akiko Ishii Breakdown of academic impact, for papers by Carlos Tarín Breakdown of academic impact, for papers by Hanna Leskinen Breakdown of academic impact, for papers by Rok Humar Breakdown of academic impact, for papers by Tatsuhiko Mori
Rankless by CCL
2026